SE432052B - Forfarande for framstellning av en topisk salva for behandling av dermatologiska akommor samt salvbas till anvendning som medel vid forfarandet - Google Patents

Forfarande for framstellning av en topisk salva for behandling av dermatologiska akommor samt salvbas till anvendning som medel vid forfarandet

Info

Publication number
SE432052B
SE432052B SE7711962A SE7711962A SE432052B SE 432052 B SE432052 B SE 432052B SE 7711962 A SE7711962 A SE 7711962A SE 7711962 A SE7711962 A SE 7711962A SE 432052 B SE432052 B SE 432052B
Authority
SE
Sweden
Prior art keywords
procedure
salvas
salvation
dermatological
topical
Prior art date
Application number
SE7711962A
Other languages
English (en)
Other versions
SE7711962L (sv
Inventor
V Ecker
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of SE7711962L publication Critical patent/SE7711962L/sv
Publication of SE432052B publication Critical patent/SE432052B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7711962A 1976-10-26 1977-10-24 Forfarande for framstellning av en topisk salva for behandling av dermatologiska akommor samt salvbas till anvendning som medel vid forfarandet SE432052B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/735,854 US4070462A (en) 1976-10-26 1976-10-26 Steroid ointment

Publications (2)

Publication Number Publication Date
SE7711962L SE7711962L (sv) 1978-04-27
SE432052B true SE432052B (sv) 1984-03-19

Family

ID=24957479

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7711962A SE432052B (sv) 1976-10-26 1977-10-24 Forfarande for framstellning av en topisk salva for behandling av dermatologiska akommor samt salvbas till anvendning som medel vid forfarandet

Country Status (14)

Country Link
US (1) US4070462A (sv)
JP (1) JPS5356316A (sv)
AU (1) AU509635B2 (sv)
BE (1) BE860071A (sv)
CH (1) CH627652A5 (sv)
DE (1) DE2747631C3 (sv)
DK (1) DK152171C (sv)
FR (1) FR2368960A1 (sv)
GB (1) GB1563757A (sv)
HK (1) HK33283A (sv)
NL (1) NL176226C (sv)
SE (1) SE432052B (sv)
SG (1) SG60482G (sv)
ZA (1) ZA776311B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
AU5794680A (en) * 1979-05-31 1980-12-04 E.R. Squibb & Sons, Inc. Corticosteroid stick formulations
CH649923A5 (de) * 1980-10-06 1985-06-28 Glaxo Group Ltd Topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide.
US4298604B1 (en) * 1980-10-06 1998-12-22 Schering Corp Clotrimazole-betamethasone dipropionate combination
DE3225848A1 (de) * 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Kortikoidhaltige zubereitung zur topischen applikation
DE3225849A1 (de) * 1982-07-07 1984-01-19 Schering Ag Kortikoidhaltige zubereitung zur topischen applikation
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
DE3341770A1 (de) * 1983-11-18 1985-05-30 Ulrich Dr.med. 2872 Hude Wilke Verwendung einer salbe oder creme fuer den analbereich
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream
JPS61247469A (ja) * 1985-04-24 1986-11-04 半井　悦朗 自動点滴ストツパ−付輸液・輸血セツト
US5041439A (en) * 1986-06-13 1991-08-20 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
GR1001303B (el) * 1989-01-23 1993-07-30 Wolff Chem Pharm Gmbh Μεθοδος παρασκευης μεσου που περιεχει σαλικυλικο οξυ εναντιον απολεπιστικων νοσων της επιδερμιδας.
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
KR20040034795A (ko) * 2002-10-17 2004-04-29 박래옥 스테로이드 제제 및 태반 추출물을 함유한 염증성 피부병치료용 경피제
US20040091539A1 (en) * 2002-11-13 2004-05-13 Ake Lindahl Dermastick thickened ointment
CA2782622C (en) 2009-12-08 2018-05-22 Healthpoint, Ltd. Enzymatic wound debriding compositions with enhanced enzymatic activity
JP5965187B2 (ja) * 2012-03-30 2016-08-03 小林製薬株式会社 油性軟膏剤
WO2022163686A1 (ja) * 2021-01-26 2022-08-04 シオノギヘルスケア株式会社 ベタメタゾン吉草酸エステル含有軟膏剤組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
IT1061787B (it) * 1967-03-01 1983-04-30 Vismara Francesco Spa Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US3755566A (en) * 1970-02-06 1973-08-28 Merck Patent Gmbh 9alpha-fluoro - 16-fluoromethyleneprednisolone-21-enanthate and process for the preparation thereof
CA989306A (en) * 1970-10-29 1976-05-18 Subramaniam Shastri Propylene carbonate ointment vehicle
BE795226A (fr) * 1972-02-11 1973-08-09 Syntex Corp Vehicule pour pommade contenant du dimethyl-2,2dioxolane-1,3 methanol-4
IL41582A0 (en) * 1972-03-03 1973-04-30 Syntex Corp Fatty alcohol-butanediol-glycol solvent cream composition
US3892856A (en) * 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
FR2368960B1 (sv) 1980-08-08
NL7711652A (nl) 1978-04-28
DK152171B (da) 1988-02-08
DK152171C (da) 1988-06-20
HK33283A (en) 1983-09-09
CH627652A5 (en) 1982-01-29
NL176226B (nl) 1984-10-16
AU509635B2 (en) 1980-05-22
DE2747631C3 (de) 1980-12-11
JPS5356316A (en) 1978-05-22
NL176226C (nl) 1985-03-18
AU2999177A (en) 1979-05-03
GB1563757A (en) 1980-04-02
DK473177A (da) 1978-04-27
FR2368960A1 (fr) 1978-05-26
DE2747631A1 (de) 1978-04-27
US4070462A (en) 1978-01-24
BE860071A (fr) 1978-04-25
ZA776311B (en) 1978-06-28
DE2747631B2 (de) 1980-04-24
SG60482G (en) 1983-09-02
JPS5732042B2 (sv) 1982-07-08
SE7711962L (sv) 1978-04-27

Similar Documents

Publication Publication Date Title
SE432052B (sv) Forfarande for framstellning av en topisk salva for behandling av dermatologiska akommor samt salvbas till anvendning som medel vid forfarandet
DK571677A (da) I 2stillingen substituerede 1,4-dihydropyridinderivater fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
SE442013B (sv) Cykliska sulfonyloxiimider for anvendning vid framstellning av cykliska aminosyror
DK413976A (da) Naphthoquinonestere og deres anvendelse som miticider og aphicider
ATA241177A (de) Kosmetisches mittel
DK683987A (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
ATA513277A (de) Kosmetisches mittel
DK107077A (da) 4,5-dichlorimidazol-2-carboxylsyrederivater, fremgangsmade til deres fremstilling samt deres anvendelse som skadedyrsbekempelsesmidler
NO145137C (no) (1-fenyl-2-triazolyl-etyl)-eter-derivater samt deres anvendelse som fungicider
DK122377A (da) 2,3,4,4a-tetrahydro-1h-pyrazino (1,2-a)quinoxalin-5(6h)-oner og derivater deraf samt deres fremstilling og anvendelse
NO147032C (no) Harpiks som kan gjoeres vannloeselig, for belegningsformaal, samt anvendelse derav i belegningspreparater
ATA513177A (de) Kosmetisches mittel
SE431201B (sv) For anvendning vid metning av kollagenasaktivitet avsett peptidderivat jemte forfarande for nemnda metning
SE7703979L (sv) 1-nitro-9-dialkylaminoisoalkylamino-akridiner, deras salter samt framstellning och anvendning derav som lekemedel
SE7708621L (sv) 2-bensyl-pyrrolidiner, sett for framstellning derav och anvendning derav som lekemedel
NO146659B (no) Kosmetiske preparater for pleie av huden
SE7507293L (sv) Forfaringsett vid forzinkning, speciellt forzinkning av gengade festorgan
DK164176A (da) Carboxylsyreamider, fremgangsmade til deres fremstilling samt deres anvendelse som legemidler
DK451080A (da) Homoserinderivater samt deres fremstilling og anvendelse som mikrobicider
AU508349B2 (en) Novel g-acetamidophenol derivatives, their preparation and their use as therapeutic agents
NO149477C (no) Fremgangsmaate for fremstilling av limt papir samt limemiddel for bruk i fremgangsmaaten
DK470177A (da) N-chloracetyl-n-phenyl-alaninestere fremgangsmaade til deres fremstilling samt deres anvendelse som fungicider
IT1115363B (it) Amminoalcossibenzofurani,loro procedimento di preparazione e loro applicazione in terapia
FI803995L (fi) Farmaceutiska blandningar som aer terapeutiskt vaerdefulla vid skoetsel av pulmonaris edema vissa choktillstaond och hyperfibrinolys samt foerfarande foer framstaellning av blandningen
SE7604140L (sv) Nya triisocyanater till anvendning vid framstellning av polyuratanplaster

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7711962-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7711962-6

Format of ref document f/p: F